United States
Cardiac Diagnostics & Monitoring

For Healthcare Professionals

3-2-1-Banner

Always on Watch

Reveal® XT Insertable Cardiac Monitor (ICM) captures the ECG you need to make informed decisions about your syncope patients and those who experience transient symptoms that may suggest a cardiac arrhythmia.

Reveal XT ICM Provides

  • 3-year longevity for long-term monitoring1
  • MR conditional labeling for safe patient management
  • Medtronic CareLink® Network compatibility for remote monitoring
  • Reveal XT Slider Image 1
  • Reveal XT Slider Image 2
  • Reveal XT Slider Image 3

Comprehensive Arrhythmia Monitoring With AF Detection

Automatically Classifies Rhythm Types

  • Atrial tachyarrhythmia/atrial fibrillation (AT/AF)
  • Ventricular tachyarrhythmia (VT)
  • Fast ventricular tachyarrhythmia (FVT)
  • Bradyarrhythmias
  • Asystole

Includes an Exclusive AF Detection Algorithm

  • May detect the presence of AT/AF, including asymptomatic episodes
  • Monitors AT/AF burden to assess whether medical treatment is necessary or should be adjusted
  • Monitors ventricular rhythm during atrial arrhythmias to assess the efficacy of rate control therapy

Click here to view or download the Reveal XT ICM Clinician Manual and MRI Checklist.

 

Next: Reveal XT ICM Implant Procedure

References
  1. Reference the Reveal XT ICM Clinician Manual for usage parameters.

‡Reveal XT ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please note that patients must wait 6 weeks post-insertion before having an MRI scan. Please see the Reveal XT ICM Clinician Manual or MRI Checklist for more details.